Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial. Once-daily oral IL-23 inhibitor icotrokinra (fo ...

After hours: March 21 at 7:55:13 PM EDT Loading Chart for DAR ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

A ridge will persist over most of the state for several days. A weak trough will linger near the southwest, contracting into northern Queensland on Wednesday or Thursday. Onshore winds will increase ...